US FDA devices chief should go on record over EU device failings in global dialogue
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration needs to work a great deal harder if it wants to demonstrate to those to whom it has public accountability in the US, and globally, that its medtech regulatory system works better overall for patients than the less prescriptive EU system.